The Nephrocare Health IPO will open on December 10 and close on December 12. The allotment is scheduled to be finalised on December 15, with the shares expected to list on December 17.
Nephrocare Health IPO Date, Review, Price, Allotment Details
Posted on: 03 Dec 2025
The Nephrocare Health IPO will open on December 10, 2025, and close on December 12, 2025. It is a Book-Building Issue, through which the company plans to raise approximately ₹[.] crores, including a fresh issue of ₹353.41 crores and an Offer for Sale of up to 1,12,53,102 equity shares with a face value of ₹2 each.
The IPO price band is ₹[.] per share. The allocation consists of 50% for QIBs, 35% for retail investors, and 15% for HNIs. The shares are expected to list on BSE and NSE on December 17, 2025, with allotment scheduled for December 15, 2025.
For FY 2025, the company reported revenue of ₹769.92 crores, up from ₹574.72 crores in FY 2024, and a profit of ₹67.10 crores compared to ₹35.13 crores in 2024. Based on these financials, the IPO appears suitable for investors with a long-term perspective.
Nephrocare Health IPO Details
IPO Open Date December 10, 2025 IPO Close Date December 12, 2025 Face Value ₹2 Per Equity Share IPO Price Band ₹[.] to ₹[.] Per Share Issue Size Approx ₹[.] Crores Fresh Issue Approx ₹353.41 Crores Offer for Sale: Approx 1,12,53,102 Equity Shares Issue Type Book Built Issue IPO Listing BSE, NSE DRHP Draft Prospectus 
RHP Draft Prospectus
Nephrocare Health IPO Market Lot
The minimum market lot for the Nephrocare Health IPO is [.] shares, requiring an application amount of ₹[.]. Retail investors can apply for up to 13 lots, totaling [.] shares, with a maximum investment of ₹[.].
Application Lot Size Shares Amount Retail Minimum – – ₹- Retail Maximum – – ₹- S-HNI Minimum – – ₹- S-HNI Maximum – – ₹- B-HNI Minimum – – ₹-
IPO Reservation
Investor Category Share Offered -% Shares Anchor Investor – Shares -% QIB (Ex. Anchor) – Shares 50% NII Shares Offered – Shares 15% Retail Shares Offered – Shares 35%
Nephrocare Health IPO Anchor Investors
Anchor Bidding Date December 9, 2025 Anchor Investors List Shares Offered [.] Shares Anchor Size [.] Cr. lock-in period end date 50% shares (30 Days) January 14, 2026 lock-in period end date 50% shares (90 Days) March 15, 2026
Nephrocare Health IPO Dates
IPO Open Date: December 10, 2025 IPO Close Date: December 12, 2025 Basis of Allotment: December 15, 2025 Refunds: December 16, 2025 Credit to Demat Account: December 16, 2025 IPO Listing Date: December 17, 2025 IPO Bidding Cut-off Time: December 12, 2025 – 5 PM
Promoters and Holding Pattern
The promoters of the company are Vikram Vuppala, Bessemer Venture Partners Trust, Edoras Investment Holdings Pte. Ltd., Healthcare Parent Limited, Investcorp Private Equity Fund II, and Investcorp Growth Opportunity Fund.
Particular Shares % Share Promoter Holding Pre Issue 9,26,50,799 78.90% Promoter Holding Post Issue – -%
Objects of the Issue & Utilisation of Proceeds
Purpose Crores Capital expenditure by the Company for opening new dialysis clinics in India and ₹129.11 Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company ₹136 General corporate purposes ₹-
About Nephrocare Health IPO
Nephrocare Health Services Ltd. has been providing comprehensive dialysis care since 2010, operating an extensive network of clinics across India and international markets. The company’s services include diagnostics, haemodialysis, home and mobile dialysis, wellness programs, and it also operates its own pharmacy.
As of March 31, 2025, Nephrocare runs a total of 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal—covering 269 towns in 21 Indian states and four union territories.
The company operates 5,068 dialysis machines, serving 29,281 patients and performing over 2.88 million dialysis sessions as of March 2025. It has partnered with leading hospitals such as Max, Fortis Escorts, Care Hospitals, Wockhardt, Paras, CMRI, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centres.
Nephrocare Health IPO Company Financial Report
Amount ₹ in Crores
Period Ended Revenue Expense PAT Assets 2023 ₹443.26 ₹451.85 ₹11.79 ₹666.23 2024 ₹574.72 ₹541.56 ₹35.13 ₹806.02 2025 ₹769.92 ₹682.48 ₹67.10 ₹996.46 September 2025 ₹483.97 ₹456.07 ₹14.23 ₹1,193.68
Nephrocare Health IPO Valuation – FY2025
Check Nephrocare Health IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
KPI Values ROE: 13.45% ROCE: -% EBITDA Margin: 22.05% PAT Margin: 8.88% Debt to equity ratio: 0.58 Earning Per Share (EPS): ₹8.28 (Basic) Price/Earning P/E Ratio: N/A Return on Net Worth (RoNW): 13.19% Net Asset Value (NAV): ₹59.56
Peer Group Comparison
Company EPS PE Ratio RoNW % NAV Income Narayana Health 38.90 50.62 NA NA 5,482.98 Cr. Jupiter Life Line Hospitals 29.47 51.27 14.27% 192.55 1,261.55 Cr. Rainbow Children Hospital 23.97 64.00 16.56% 134.67 1,515.87 Cr. Dr. Agarwal’s Healthcare 2.80 155.32 NA NA 1,711 Cr. Vijaya Diagnostics 13.95 73.20 NA NA 681.39 Cr. Dr. Lal Path Labs 58.48 50.75 22.30% 244.39 2,461.40 Cr. Metropolis Healthcare 28.29 73.10 NA NA 1,331.20 Cr.
IPO Lead Managers aka Merchant Bankers
- ICICI Securities Ltd.
- Ambit Pvt.Ltd.
- IIFL Capital Services Ltd.
- Nomura Financial Advisory & Securities (India) Pvt.Ltd.
Company Address
Nephrocare Health Services Ltd.
5 th Floor, D Block, iLabs Centre,
Plot 18, Software Units Layout,
Survey No. 64, Madhapur, Shaikpet,
Hyderabad, Telangana, 500081
Phone: +91 40 4240 8039
Email: cs@nephroplus.com
Website: http://www.nephroplus.com/
IPO Registrar
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: nephrocare.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/